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 Patient: Female, 49
 Final Diagnosis: Anti-LGI1 limbic encephalitis
 Symptoms: Seizure • sinus arrest
 Medication: —
 Clinical Procedure: Immunosupression
 Specialty: Neurology
 Objective: Rare co-existance of disease or pathology
 Background: Anti-LGI1 encephalitis is a type of autoimmune limbic encephalitis. This case report elucidates features of anti-
LGI1 limbic encephalitis, focusing on clinical findings and outcome as well as on rarely reported sinus arrest 
and its pathophysiology.
 Case Report: A 49-year-old female patient presented at the Emergency Department (ED) because of twitching and an acute 
confusional state. Initial neurological examination revealed cognitive disturbance with disorientation, inatten-
tion, and amnestic deficits. While in the ED, twitching of the right arm was observed and shortly thereafter she 
experienced a sinus arrest. A temporary cardiac pacemaker was implanted. Laboratory investigations demon-
strated mild hyponatremia and positive LGI1-IgG antibodies in serum. An initial head MRI was unremarkable 
and electroencephalography showed epileptic seizure activity starting focally in the left hemisphere synchro-
nous with the intermittent twitching of the right arm. A seizure-suppressant therapy with levetiracetam, val-
proate, and gabapentin was initiated, as well as an immunosuppressive pulse therapy with methylpredniso-
lone followed by a tapering oral regimen of prednisolone. Within a few days, the seizures ceased. One month 
later, neurocognitive test results were back to normal. At 2 years, mild depressive symptoms and anxiety dis-
order were the main clinical problems, as well as episodic migraine-like headaches.
 Conclusions: Repetitive focal dystonic seizures, confusion, amnestic deficits, sinus arrest, and mild-to-moderate hyponatre-
mia are pathognomonic features of anti-LGI1 limbic encephalitis. Sinus arrest may occur because of a direct 
pathophysiological dysfunction of the structures involved in autonomic cardiac rhythm control or as an ictal 
or postictal phenomenon. Early diagnosis and initiation of immunosuppressive therapy are both of utmost im-
portance for favorable clinical outcome.
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Background
Anti-LGI1 encephalitis is a type of autoimmune limbic enceph-
alitis. This case report elucidates features of anti-LGI1 limbic 
encephalitis, focusing on clinical findings and outcome as well 
as on rarely reported sinus arrest and its pathophysiology.
Case Report
A 49-year-old female patient was taken to our Emergency 
Department (ED) because of twitching and an acute confu-
sional state. On the day before admission, her daughter had 
found her staring at her without reaction for 5–6 s, then she 
started twitching with her arm(s) for several seconds and af-
terwards began to ask the same questions repeatedly, such 
as ‘Where am I?’.
The patient had last been seen the day before, appearing well. 
The week before, she had complained about an episode of ver-
tigo. A subsequent outpatient continuous monitoring of the 
blood pressure had failed to show any arterial hypotonia, as 
initially suspected by the treating general practitioner. He then 
had proposed probatory betahistine, which the patient refused 
to take. The past medical and family history were unremarkable.
On initial neurological examination at our ED, the patient was 
disoriented to time, place, and situation, and was inattentive 
(e.g., calculating and spelling of single words backwards was 
not possible, and the forward digit-span was 3 out of 5 digits). 
Further pathological somatic neurological findings were absent. 
On admission, laboratory investigations displayed moderate 
hyponatremia (130 mmol/l, normal range 136–145 mmol) and 
a slight elevation of NT-proBNP (261pg/ml, normal <169 pg/ml). 
Creatinine, CRP, ASAT, GGT, LDH, creatinine-kinase, troponin-T, 
TSH, blood glucose, hemogram, and coagulation parameters 
were normal. A basic cerebrospinal examination revealed no 
abnormalities (protein 0.24 g/l, glucose 3.68 mmol/l, lactate 
1.5 mmol/l, erythrocyte count <1×106/l, cell-count 1×106/l, 
albumin 144 g/l, no intrathecal production of antibodies). Also, 
an MRI of the head (Figure 1) did not show any relevant pa-
thology. However, while at our ED, intermittent involuntary dys-
tonic twitches of the right arm were observed. They turned out 
to be focal seizures, as they correlated with electroencephalo-
graphic seizure activity starting focally in the contralateral left 
hemisphere (Figure 2). Also, while lying in our ED bed being 
monitored, a syncope due to a 17-s sinus arrest without ven-
tricular escape beat emerged, preceded by a short period of 
sinus bradycardia without AV block (Figure 3). Therefore, the 
patient was transferred to the intensive care unit and a tem-
porary cardiac pacemaker was implanted.
Figure 1.  MRI of the head. FLAIR-sequence 
showing normal brain parenchyma 
including hippocampi.
Figure 2.  Electroencephalography during 
a dystonic brachial seizure. 
Electroencephalography showing 
ictal event starting focally in the 
left hemisphere with underlying 
theta and delta waves in frontal and 
central location and left-dominant 
frontotemporal propagation including 
changes of frequency and amplitude 
and with steep alpha waves resulting 
in a dystonic brachial seizure clinically.
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Further immune-serological investigations (Figure 4) revealed 
positive leucine-rich glioma inactivated (LGI)-1 antibodies in 
serum (1: 80, normal <1: 10). In the cerebrospinal fluid, the 
LGI-1 antibodies were negative, as were other investigations 
of infectious diseases, autoimmune, and paraneoplastic anti-
bodies. Although anti-LGI-1 limbic encephalitis rarely is the re-
sult of a paraneoplastic process, a chest and abdomen CT and 
a gynecological evaluation were performed, which showed no 
evidence of cancer.
Intravenous pulse therapy with 1 g methylprednisolone over 
5 days followed by an oral regimen of prednisolone (1 mg/kg 
with tapering over 3 months) was initiated. At first, the seizure-
suppressant therapy consisted of levetiracetam 1 g twice daily. 
Because of focal seizure persistence, gabapentin and valproate 
extended release (1200 mg/day each) were added. Under this 
treatment regimen, the seizures ceased within a few days. As no 
other episodes with sinus arrest occurred, the temporary car-
diac pacemaker was removed after 9 days and the patient was 
transferred to our inpatient rehabilitation clinic. We observed 
inattention and impairment of short-term memory, as well as 
visuoconstruction and executive function impairment. Because 
of depressive symptoms, venlafaxine therapy was started.
One month later, neurocognitive testing was back to normal. 
One year later, the depressive symptoms, for which an outpa-
tient psychiatric treatment was initiated and newly-occurred 
migraine-like headaches prevailed. For 2 years, the patient re-
mained clinically seizure-free and there was no epileptic ac-
tivity in routine electroencephalography. Therefore, gabapen-
tin and levetiracetam were stopped but valproate extended 
release 1200 mg/day was continued because of persistent 
episodic migraine-like headaches. At 2 years, mild depres-
sive symptoms and newly-occurred anxiety disorder were the 
main clinical problems, so the outpatient psychiatric treat-
ment was continued.
Discussion
The prerequisite for the correct diagnosis of an autoimmune 
anti-LGI-1 limbic encephalitis in this patient was a high clin-
ical suspicion due to the combination of repetitive focal dys-
tonic seizures, confusion, amnestic deficits, sinus arrest, and 
mild- to-moderate hyponatremia at presentation. However, 
the unremarkable MRI of the head and the normal basic cere-
brospinal fluid results were challenging.
In a case series of anti-LGI1 encephalitis including 38 patients, 
hippocampal lesions were seen in 74% of patients, an unre-
markable basic cerebrospinal fluid examination result was seen 
in 75%, and hyponatremia was seen in 65% [1].
In the early stage of the disease, the diagnosis is best recog-
nized on clinical grounds [1,2–7]. Faciobrachial dystonic sei-
zures (abr. FBDS) are considered as pathognomonic for anti-
LGI1 limbic encephalitis [5]. The isolated involvement of one 
arm, as in our patient, has been reported before [4]. There may 
also be other epileptic seizures with temporal focus and pos-
sibly secondary generalization and impaired consciousness, 
cognitive impairment (e.g., of short-term memory, attention, 
and orientation), psychiatric symptoms (e.g., paranoia, depres-
sion, dysphoria, anxiety, and visual hallucinations), sleep dis-
orders, and autonomic dysfunction (e.g., cardiac arrhythmia, 
sexual dysfunction, and sweating).
Syncopes have been previously described in association with 
limbic encephalitis, mostly of the anti-NMDA, but also GABA-
B-receptor type [8–12]. We have found 4 published cases with 
syncope [13,14] and 2 with bradycardia [3] caused by anti-
LGI1 limbic encephalitis. The predominant mechanism has 
been identified as sinus arrest preceded by sinus dysrhyth-
mia/bradycardia [10,12].
Figure 4.  Panel with the most common 
antibodies causing limbic encephalitis. 
Positive LGI-1 antibodies in serum 
(1: 80). The technique used was 
indirect immunofluorescence using 
a commercial kit (Euroimmun 
Switzerland AG).
Figure 3.  Electrocardiography. Sinus bradycardia 
without AV block followed by sinus 
arrest.
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Different pathophysiological mechanisms for sinus arrest in 
limbic encephalitis have been discussed.
On the one hand, a direct pathophysiological dysfunction of the 
structures that play a role in autonomic cardiac rhythm con-
trol seems plausible, since attacked receptors are expressed 
in them as follows [6,15]: NMDA-receptors are scattered along 
the intra-cardiac conduction system, the vagal nuclei and the 
nucleus of the solitary tract (NTS) [12]. The GABA-B-receptors 
also have been found in the NTS and vagal nuclei [10]. LGI1 
protein is known to be present throughout the neocortex, such 
as in the temporal lobe, the insular region, the hippocampus, 
and the hypothalamus [7,13,14,16]. These structures play an 
important role in central regulation of autonomic function [15]. 
On the other hand, sinus arrest in limbic encephalitis might 
also be an ictal or postictal phenomenon since it affects the 
temporal lobe. This has been thoroughly elucidated before [15].
In our patient, the episode of vertigo 1 week before admission 
possibly was a first manifestation of cardiac arrhythmia (but 
not retrospectively verifiable) related to the autoimmune anti-
LGI-1 limbic encephalitis. The etiology of the proven sinus ar-
rest remains uncertain. The sinus arrest happened after onset 
of focal seizures and confusional state and not as a prodro-
mal phenomenon or after a vagal stimulus, as also has been 
depicted in the literature [13,14].
Seizures ceased in our patient within a few days of treatment, 
but this happens in only around 10% of patients with anti-LGI1 
limbic encephalitis, despite seizure-suppressant therapy, and 
in 51% and 88% after 30 and 90 days, respectively, in patients 
receiving additional immunosuppressive therapy [6]. Also, our 
patient fully recovered cognition, although only about 35% of 
patients do so [17].
In described disease progression, unilateral tonic-dystonic 
seizures first occur, then they become bilateral, there may be 
frontal or temporal lobe epilepsy, and persistent cognitive im-
pairment and status epilepticus finally develop [4]. An asso-
ciation between faciobrachial dystonic seizures duration and 
cognitive impairment has also been described. Cognitive im-
pairment is reported in 38% of patients after 30 days, and in 
56% of patients after 90 days [6].
The good recovery in our patient was likely due to the dis-
ease being at its initial stage upon admission and due to early 
initiation of immunosuppressive therapy, which are both of 
utmost importance for favorable clinical outcome [4–6,18]. 
There are currently no randomized trials of long-term immuno-
suppression in patients with anti-LGI1 limbic encephalitis [19]. 
Observational studies have shown a benefit. However, in our 
patient, we decided on the therapy regime described above 
because we wished to lower the risk of potential relevant ad-
verse effects of long-term immunosuppression. Because there 
was good clinical recovery and no relapses, we did not have 
to reinitiate immunosuppression.
LGI-1 antibodies in CSF were negative in our patient, high-
lighting the higher sensitivity of detection of anti-LGI1 anti-
bodies in serum compared to CSF [3,8]. Recently, it also has 
been discovered that involvement of anti-LGI1 IgG1 antibodies, 
which fixate complement, is associated with worse cognitive 
impairment and long-term disability than with involvement of 
non-fixating complement anti-LGI1 IgG4 antibodies [6]. In our 
patient, we investigated total anti-LGI1 IgG antibodies only.
To date, 2 years after disease onset, there was no evidence of 
any relapse in our patient in the outpatient follow-up visits. 
Because of considerable relapse rates (27% [17] according 
to Ariño et al. and 35% [1] according to van Sonderen et al.) 
and the relatively long time-span in which relapses may oc-
cur (up to 8 years [1] after disease onset), a long-term outpa-
tient follow-up is also of importance.
To the best of our knowledge, psychiatric symptoms as an 
outcome parameter and onset of migraine-like headaches af-
ter anti-LGI1 limbic encephalitis have not yet been explored 
in literature. However, the latter likely is a secondary head-
ache phenomenon.
Conclusions
At an early stage, the diagnosis of anti-LGI1 limbic encephali-
tis is easy to miss. However, repetitive focal dystonic seizures, 
confusion, amnestic deficits, sinus arrest, and hyponatremia 
combined are highly pathognomonic of anti-LGI1 limbic enceph-
alitis. Sinus arrest may occur because of a direct pathophys-
iological dysfunction of the structures involved in autonomic 
cardiac rhythm control or as an ictal or postictal phenomenon. 
Early recognition of the disease and timely treatment initia-
tion are of utmost importance for favorable clinical outcome.
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